Antioxidant and cholinergic neuroprotective mechanisms in experimental parkinsonism

Funct Neurol. 2002 Jan-Mar;17(1):37-44.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Cholinergic Agents / therapeutic use*
  • Neuroprotective Agents / therapeutic use*
  • Oxidative Stress / drug effects
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / drug therapy*
  • Parkinson Disease, Secondary / physiopathology*
  • Rats
  • Receptors, Nicotinic / drug effects
  • Substantia Nigra / pathology
  • Substantia Nigra / physiopathology

Substances

  • Antioxidants
  • Cholinergic Agents
  • Neuroprotective Agents
  • Receptors, Nicotinic